Admission Date:  [**2127-3-29**]     Discharge Date:  [**2127-4-1**]  Date of Birth:   [**2087-9-24**]     Sex:  F  Service:  TRANSPLANT SURGERY  HISTORY OF PRESENT ILLNESS:  The patient is a 39 year-old female status post living related kidney transplant on [**2127-3-19**].
She complained earlier in the week of a neck ache, however, she was otherwise well.
She was started on a Nipride drip and transferred to [**Hospital1 188**].
She is brought to the Neurosurgery Intensive Care Unit where she was started on a Labetalol drip.
End stage renal disease secondary to IGA nephropathy, hemodialysis times two months prior to living related kidney transplant on [**2127-3-19**].
MEDICATIONS:  Cyclosporin 250 mg b.i.d., Prednisone 20 mg q.d., CellCept one gram b.i.d., INH 30 mg q.d., B-6 50 mg q.d., Lopressor 25 mg b.i.d., Ganciclovir 500 mg t.i.d., Colace 100 mg po b.i.d.
O2 saturation 100% on 2 liters.
HOSPITAL COURSE:  The patient's blood pressure was controlled on a Labetalol drip in the Intensive Care Unit.
A neurosurgery consult was obtained as a result of pain and an MRI was performed, which revealed white matter patchy changes in the occipital lobe consistent with Cyclosporin toxicity.
The patient was switched to Rapamune 10 mg po q day times three days and then 5 mg po q day.
The patient was followed closely by renal and her hypertension was controlled with a regimen of Enalapril 10 mg q.d., Lopressor 12.5 mg q.d., and Hydralazine 10 mg po q.i.d.
DISCHARGE MEDICATIONS:  CellCept [**Pager number **] mg po q.i.d., B-6 50 mg q.d., Ganciclovir 500 mg t.i.d., Prednisone 20 mg po q.d., INH 300 mg q.d., Rapamune 5 mg po q.d., Enalapril 10 mg po q.d., Hydralazine 10 mg po q 6 hours, Lopressor 12.5 mg b.i.d.
Cyclosporin related seizures.
